Skip to main content
. 2019 Oct 14;11(10):534. doi: 10.3390/pharmaceutics11100534

Figure 2.

Figure 2

Schematics of the generation of functional virus-like particle (VLP) and (A) the delivery of proteins of interest intracellularly, and (B) by receptor/ligand-mediated protein delivery. Reproduced with permission from Ref. [57]; Copyright © 2011, National Academy of Sciences.